Citation

BibTex format

@article{Wainwright:2025:10.1164/rccm.202502-0512OC,
author = {Wainwright, C and McColley, SA and McNally, P and Powers, M and Ratjen, F and Rayment, JH and Retsch-Bogart, G and Roesch, E and Ramsey, B and Mckone, EF and Tullis, E and Mall, MA and Taylor-Cousar, JL and Waltz, D and Ahluwalia, N and Chu, C and Scirica, C and Davies, JC},
doi = {10.1164/rccm.202502-0512OC},
journal = {AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE},
pages = {1915--1925},
title = {Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A 192-Week, Phase 3, Open-Label Extension Study},
url = {http://dx.doi.org/10.1164/rccm.202502-0512OC},
volume = {211},
year = {2025}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Wainwright,C
AU  - McColley,SA
AU  - McNally,P
AU  - Powers,M
AU  - Ratjen,F
AU  - Rayment,JH
AU  - Retsch-Bogart,G
AU  - Roesch,E
AU  - Ramsey,B
AU  - Mckone,EF
AU  - Tullis,E
AU  - Mall,MA
AU  - Taylor-Cousar,JL
AU  - Waltz,D
AU  - Ahluwalia,N
AU  - Chu,C
AU  - Scirica,C
AU  - Davies,JC
DO  - 10.1164/rccm.202502-0512OC
EP  - 1925
PY  - 2025///
SN  - 1073-449X
SP  - 1915
TI  - Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A 192-Week, Phase 3, Open-Label Extension Study
T2  - AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
UR  - http://dx.doi.org/10.1164/rccm.202502-0512OC
VL  - 211
ER  -
Download